FDA has compiled a document containing more than 1000 Class II devices that the agency is suggesting be exempt or partially exempt from 510(k) requirements. Listed in the Federal Register, these devices do not present risks that require premarket notification review in order to provide reasonable assurance of safety and effectiveness, according to FDA.
“Medical devices that are exempt from 510(k) are not exempt from other regulatory controls. All medical devices must be manufactured under current good manufacturing practice requirements, be suitable for the intended use, be adequately packaged and properly labeled, and have establishment registration and device listing forms on file with the FDA.” – FDA
The agency has published the notice and is requesting public comment, which ends on May 15, as part of the procedures established by the 21st Century Cures Act.
Related Articles
-
The draft guidance proposes updates to clarify how the Breakthrough Devices Program may be applicable to certain medical devices that promote health equity, as well as considerations in designating eligible devices that may benefit populations impacted by disparities in health…
-
With the ever-increasing adoption of connected devices, the agency is emphasizing the need for effective cybersecurity.
-
The FDA is hosting a webinar on February 2 for interested stakeholders to discuss the final guidance Electromagnetic Compatibility (EMC) of Medical Devices and its applicability to in vitro diagnostic (IVD) devices.
-
Effective February 7, the agency will conduct inspections across all commodities, as well as mission-critical foreign and domestic inspections.
